Cassava Sciences GAAP EPS of -$0.58 beats by $0.30

  • Cassava Sciences press release (NASDAQ:SAVA): Q3 GAAP EPS of -$0.58 beats by $0.30.
  • $149.0 Million in Cash and Cash Equivalents at September 30, 2024. Expected To Support Operations Into 2026

Leave a Reply

Your email address will not be published. Required fields are marked *